China's Biotech Renaissance

This chapter analyzes China's transformation into a global leader in pharmaceutical innovation, evolving from generic drug production to developing cutting-edge treatments. It highlights the strategic initiatives and return of overseas-trained scientists that have spurred rapid growth in the biotech sector, while also discussing the impact on Western pharmaceutical companies amid a looming patent cliff. The chapter underscores the broader implications of U.S.-China relations on drug licensing and market dynamics in the context of an increasingly competitive landscape.